Pan-cancer analysis and validation show GTF2E2’s diagnostic, prognostic, and immunological roles in regulating ferroptosis in endometrial cancer
PLOS One · 2025
DOI: 10.1371/journal.pone.0321983 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Nie Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Fuyang Hospital of Anhui Medical University, Fuyang, China. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Ferroptosis, Transcription Factors, TFII. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anhui University Natural Science Research Project, Research Fund of Anhui Institute of Translational Medicine, Research Fund Project of Anhui Medical University.
Abstract (Originalsprache)
Background
Transcription initiation factor IIE subunit beta (GTF2E2) is a crucial component of the RNA polymerase II transcription initiation complex. There is a lack of more detailed research on the biological function of GTF2E2 in pan-cancer.
Methods
We conducted a comprehensive pan-cancer analysis using data from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) project. Employing a multi-pronged approach with tools including R, Cytoscape, TISIDB, cBioPortal, STRING, GSCALite, and CancerSEA, we investigated GTF2E2’s expression patterns, prognostic value, mutational landscape, functional enrichment, and immunological associations across 33 cancer types. Besides, we further validated the bioinformatic results through in vitro experiments in Uterine corpus endometrial carcinoma (UCEC), including western blotting (WB), cell proliferation assays and transwell. DCFH-DA, C11-BODIPY 581/591 and FeRhoNox-1 probes were performed to identify ferroptosis levels in vitro.
Results
GTF2E2 expression was significantly elevated in most cancers compared to normal tissues, with notable diagnostic potential (AUC > 0.7) in 20 cancer types. GTF2E2 expression varied across molecular and immune subtypes and correlated with tumor stage and patient age in several cancers. Functional enrichment analyses highlighted GTF2E2’s involvement in key cancer-related and immunological pathways. Notably, GTF2E2 promoted UCEC progression in vitro, and knockdown of GTF2E2 significantly inhibited the proliferation, migration and invasion of UCEC cells. Compared with the control group, GPX4 expression was down-regulated and ACSL4 expression was up-regulated in the GTF2E2-knockdown group. Knockdown of GTF2E2 also increased the intracellular levels of Fe 2+ , lipid peroxides (LPOs) and reactive oxygen species (ROS).
Conclusions
Our findings underscore GTF2E2’s multifaceted roles in cancer biology, highlighting its potential as a diagnostic biomarker, prognostic indicator, and immunotherapeutic target across various malignancies. This investigation has the potential to contribute significantly to a deeper understanding of the substantial involvement of GTF2E2 in human malignancies, particularly UCEC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Fuyang Hospital of Anhui Medical University, Fuyang, China.
- Graduate School of Anhui Medical University, Anhui, China.
- Key Laboratory of Gametes and Abnormal Reproductive Tract of National Health Commission, Anhui Medical University, Anhui, China.
ORCID-Profile: Fei Zhong
Förderung
- Anhui University Natural Science Research Project
- Research Fund of Anhui Institute of Translational Medicine
- Research Fund Project of Anhui Medical University
- Anhui Provincial Key Research and Development Project
- Science Research Project of Anhui Health Commission
- Scientific Research Program of Fuyang Municipal Health Commission
Zitieren
APA
Zhang, N., Qin, X., Liu, J., Han, K., Kang, M., Zhu, Z., Zhang, D., & Zhong, F. (2025). Pan-cancer analysis and validation show GTF2E2’s diagnostic, prognostic, and immunological roles in regulating ferroptosis in endometrial cancer. PLOS One. https://doi.org/10.1371/journal.pone.0321983
Vancouver
Zhang N, Qin X, Liu J, Han K, Kang M, Zhu Z, et al. Pan-cancer analysis and validation show GTF2E2’s diagnostic, prognostic, and immunological roles in regulating ferroptosis in endometrial cancer. PLOS One. 2025. doi:10.1371/journal.pone.0321983
BibTeX
@article{Zhang2025,
author = {Zhang, Nie and Qin, Xuejin and Liu, Jingjing and Han, Ke and Kang, Manman and Zhu, Zhengchun and Zhang, Di and Zhong, Fei},
title = {Pan-cancer analysis and validation show GTF2E2’s diagnostic, prognostic, and immunological roles in regulating ferroptosis in endometrial cancer},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0321983}
}
EUVIMED